Stockreport

PTC Therapeutics Presents New Sepiapterin Data from Ongoing Studies

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com
PDF — Results show 97% of phenylalanine (Phe) tolerance study participants were able to increase their dietary Phe intake with a mean increase of 126% —— Genetic variant ana [Read more]